Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

-64.76

21.51

111.64

151.86

108.33

Net cashflow-operating activity

241.74

-282.69

282.76

148.84

39.97

Net cash used in investing activity

-182.58

18.78

-275.64

50.88

-166.06

Netcash used in fin. activity

10.82

250.73

-48.64

-203.56

123.26

Net inc/dec in cash and equivlnt

69.98

-13.18

-41.52

-3.84

-2.83

Cash and equivalnt begin of year

12.12

25.30

66.82

69.47

72.30

Cash and equivalnt end of year

82.11

12.12

25.30

65.63

69.47